The intricate relationship between IL-6 levels and insulin resistance severity, as illustrated by scatter plot and ROC curve analyses in our study, suggests a complex, potentially nonlinear interaction that may hold significant clinical implications for the therapeutic management of insulin resistance among PCOS patients. The gene discussed is IL6; the disease is polycystic ovary syndrome.